IL6 and hepatocellular carcinoma: It was reported that IL-6 trans-signaling is required to promote the development of HCC by preventing DNA-damage-induced hepatocyte apoptosis and inducing endothelial cell proliferation, which in turn promotes tumor angiogenesis [33].